Loading...

Brefeldin A Solution (1,000X)

Pricing & Availability
Regulatory Status
RUO
Other Names
BFA
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420601 1 mL 52€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Brefeldin A (BFA) is a protein transport inhibitor commonly used to enhance intracellular cytokine staining signals by blocking transport processes during cell activation. Especially useful for the intracellular staining of cytokines, BFA leads to the accumulation of most cytokines at the Golgi Complex/Endoplasmic Reticulum (see Jung, et al., 1993). Optimal conditions for use are cell type and time-dependent. Typically, protein transport inhibitors are included during in vitro cell activation cultures for 4-24 hours prior to harvest (see references below for additional information). Brefeldin A Solution is supplied as a 1,000X solution, which should be diluted to 1X in cell culture medium.

Product Details
Technical Data Sheet (pdf)

Product Details

Formulation
Brefeldin A Solution is supplied as a 1000X in DMSO, which should be diluted to 1X in cell culture medium.
Concentration
5.0 mg/ml
Storage & Handling
Store the Brefeldin A Solution (1,000X) between 2°C and 8°C. Note: DMSO freezes at this temperature.
Application

ICFC - Quality tested
Recommended Usage

Dilute the 1000X solution to 1X in the tissue culture medium. It is recommended that cells are cultured with brefeldin A for ≤ 24 hours, as this can become toxic for cell viability.

Application Notes

Completely thaw the solution before use, DMSO freezes at 4°C.  We recommend aliquotting the reagent into smaller volumes to avoid repeated freeze-thawing.  

Application References
  1. O'Sullivan BJ, et al. 2006. J. Immunol. 176:7278.
  2. Fuse S, et al. 2007. J. Immunol. 178:5227.
  3. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  4. Redfern CH,et al.2006.J. Clin Oncol.19:3107. PubMed
  5. Smithey MJ, et al. 2008. J. Immunol. 180:3406. PubMed
  6. Elzey BD, et al. 2008. Blood 111:38684. PubMed
  7. Nguyen KD, et al. 2008. J. Immunol. 181:5386. PubMed
  8. Miner MD, et al. 2008. Microb Pathog. 45:273. PubMed
  9. Goodridge HS, et al. 2009. J. Immunol. 182:1146. PubMed
  10. Markey KA, et al. 2009. Blood 113:5644. PubMed
  11. Wilcox RA, et al. 2009. Blood PubMed
  12. Zenaro E, et al. 2009. J. Leukoc Bio. PubMed
  13. Rozkova D, et al. 2009. Clin Immunol. 131:1. PubMed
  14. Butcher JP, et al. 2010. Clin Cancer Res. 16:2065.
  15. Boisvert M, et al. 2010. J. Virol. 84:7782. PubMed
  16. Liu WC, et al. 2010. J. Virol. 84:12011.15. Tawara I, et al. 2011. Clin Cancer Res. 17:77. PubMed
  17. Iwata Y, et al. 2011. Blood. 117:530. PubMed
  18. Schmidt NW, et al. 2011. J. Immunol. 186:3836. PubMed
  19. Langkjaer A, et al. 2012. Clin Immunol. 145:1. PubMed
  20. Molinero LL, et al. 2012. PNAS. 109:18529. PubMed
  21. Li HW, et al. 2012. J. Immunol. 189:5572. PubMed
  22. Wang JM, et al. 2013. J. Virol. 87:4372. PubMed
  23. Fukuoka A, et al. 2013. Int Immunol. 25:373. PubMed
  24. Wang Jm, et al. 2013. J Virol. 87:11626. PubMed
  25. Lee TH, et al. 2013. J Biol Chem. 288:32873. PubMed
  26. Shi L, et al. 2014. J. Immunol. 192:649. PubMed
  27. Bulati M, et al. 2014. Exp Gerontol. PubMed
  28. Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed
  29. Tuna H, et al. 2014. J Leukoc Biol. 95:471. PubMed
  30. Miller ML, et al. 2014. PNAS. 111:7397. PubMed
  31. Wang Y, et al. 2014. Sci Rep. 4:5346. PubMed
  32. Zhou GL, et al. 2014. J Cell Sci. 127:3916. PubMed
  33. Rist MJ, et al. 2015. J Virol. 89:703. PubMed
Product Citations
  1. Wang R, et al. 2018. Oncoimmunology. 7:e1461303. PubMed
  2. Persaud AT, et al. 2022. J Leukoc Biol. 111:573. PubMed
  3. Yu L, et al. 2022. FEBS J. 289:3241. PubMed
  4. Ritzel RM, et al. 2022. Geroscience. 44:1407. PubMed
  5. D'Angeli V, et al. 2022. Eur J Immunol. 52:1058. PubMed
  6. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  7. Kanbar JN, et al. 2022. J Exp Med. 219: . PubMed
  8. Minichino D, et al. 2022. J Leukoc Biol. 112:1089. PubMed
  9. Gao KM, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202327119. PubMed
  10. Liu H, et al. 2022. Cell Rep Med. 3:100660. PubMed
  11. Jondle CN, et al. 2022. J Virol. 96:e0063922. PubMed
  12. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  13. Hsieh T, et al. 2022. Front Immunol. 13:901030. PubMed
  14. Li FL, et al. 2022. EMBO J. 41:e110698. PubMed
  15. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  16. Dutt TS, et al. 2022. Cell Rep. 41:111783. PubMed
  17. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  18. Shamriz O, et al. 2023. Front Immunol. 13:1044933. PubMed
  19. Chan L, et al. 2022. Cells. 12: . PubMed
  20. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  21. Nanishi E, et al. 2023. NPJ Vaccines. 8:18. PubMed
  22. Hajjar S, et al. 2022. Cell Death Differ. 29:585. PubMed
  23. Li Y, et al. 2022. Brain Behav Immun. 101:1. PubMed
  24. Zander R, et al. 2022. Immunity. 55:475. PubMed
  25. Pymm P, et al. 2022. Cell Rep. 38:110449. PubMed
  26. Giles JR, et al. 2022. Immunity. 55:557. PubMed
  27. Ye L, et al. 2022. Cell Metab. 34:595. PubMed
  28. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  29. Zhao Y, et al. 2022. ACS Appl Mater Interfaces. 14:21872. PubMed
  30. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  31. Sun Y, et al. 2022. STAR Protoc. 3:101479. PubMed
  32. Redelman-Sidi G, et al. 2022. Cancer Immunol Res. 10:1241. PubMed
  33. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  34. Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed
  35. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  36. Yang WL, et al. 2023. Nat Commun. 14:863. PubMed
  37. Wu Z, et al. 2023. EMBO Rep. 24:e56524. PubMed
  38. Li G, et al. 2023. Cell Death Dis. 14:185. PubMed
  39. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  40. Mohammadpour H, et al. 2023. Cell Rep. 42:112250. PubMed
  41. Jung HY, et al. 2023. Oncoimmunology. 12:2190671. PubMed
  42. Li Y, et al. 2023. Vaccines (Basel). 11:. PubMed
  43. Onyshchenko K, et al. 2023. Nat Commun. 14:2087. PubMed
  44. Zhou X, et al. 2023. Sci Rep. 13:6701. PubMed
  45. Ko ES, et al. 2023. Cell Commun Signal. 21:107. PubMed
  46. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  47. Thomas OG, et al. 2023. Sci Adv. 9:eadg3032. PubMed
  48. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  49. Adamo S, et al. 2023. Cell Host Microbe. 31:928. PubMed
  50. LaPorte KM, et al. 2023. J Immunother Cancer. 11:. PubMed
  51. Patskovsky Y, et al. 2023. Nat Commun. 14:3763. PubMed
  52. Wang Y, et al. 2014. Sci Rep. 4:5346. PubMed
  53. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  54. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  55. Chen J, et al. 2022. Adv Healthc Mater. 11:e2101714. PubMed
  56. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  57. Yakkala C, et al. 2021. Front Immunol. 12:695150. PubMed
  58. Zheng B, et al. 2021. Int J Mol Sci. 22: . PubMed
  59. Alexander KL, et al. 2021. Gastroenterology. 161:522. PubMed
  60. Trinks N, et al. 2021. Commun Biol. 4:1151. PubMed
  61. Zhu S, et al. 2017. Exp Cell Res.. 10.1016/j.yexcr.2017.10.013. PubMed
  62. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  63. Pablo-Bernal R, et al. 2016. J Gerontol A Biol Sci Med Sci. 71: 610 - 618. PubMed
  64. Tuna H, et al. 2014. J Leukoc Biol. 95:471. PubMed
  65. Xin G, et al. 2021. Cancer Immunol Res. 9:454. PubMed
  66. Rodrigues M, et al. 2022. Biochem J. 479:1891. PubMed
  67. Nesterenko PA, et al. 2021. Cell Rep. 37:110167. PubMed
  68. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  69. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  70. Fote GM, et al. 2022. J Cell Sci. 135:. PubMed
  71. Aguilar-Pineda JA, et al. 2021. iScience. 24:102993. PubMed
  72. Moudra A, et al. 2021. J Immunol. 206:2109. PubMed
  73. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  74. Yamamoto A, et al. 2019. J Clin Invest. 129:3640. PubMed
  75. Maschmeyer P, et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.11.005. PubMed
  76. Shi L, et al. 2014. J Immunol. 192:649. PubMed
  77. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  78. Weng RR, et al. 2021. Nat Commun. 12:2163. PubMed
  79. Piper CJM, et al. 2020. Cell Reports. 29(7):1878-1892.e7.. PubMed
  80. Just S, et al. 2016. Sci Rep. 6:39796. PubMed
  81. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  82. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  83. Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed
  84. Krone A, et al. 2022. Sci Rep. 218:. PubMed
  85. Michaud D, et al. 2022. Front Immunol. 12:745873. PubMed
  86. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  87. Gay MD, et al. 2020. Cancer Prev Res (Phila). . PubMed
  88. Nguyen K, et al. 2008. J Immunol. 181:5386. PubMed
  89. Wilcox R, et al. 2009. Blood. 114:2936. PubMed
  90. Starnbach X 2015. J Immunol. 195: 1665-1675. PubMed
  91. Garg B, et al. 2016. Mutagenesis. 10.1093/mutage/gew023. PubMed
  92. Ruhland M, et al. 2016. Nat Commun. 7:11762. PubMed
  93. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  94. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  95. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  96. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  97. Almshayakhchi R, et al. 2021. Front Oncol. 11:636977. PubMed
  98. Smithey M, et al. 2008. J Immunol. 180:3406. PubMed
  99. Rana A, et al. 2020. Front Immunol. 11:536. PubMed
  100. Dayoub O, et al. 2017. Sci Rep. 10.1038/s41598-017-09933-4. PubMed
  101. Kang X, et al. 2022. Vaccines (Basel). 10:. PubMed
  102. Griffiths K, et al. 2016. Nat Commun. 7:13894. PubMed
  103. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  104. Al-Attar A, et al. 2016. Data Brief. 8: 536-44. PubMed
  105. Gonzalez-Perez G, et al. 2016. J Immunol. 196: 3768 - 3779. PubMed
  106. Pablo-Bernal R, et al. 2015. J Infect Dis. 10.1093/infdis/jiv520. PubMed
  107. Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed
  108. Jeong J, et al. 2021. Immune Netw. 21:e31. PubMed
  109. Jondle CN, et al. 2021. MBio. 12:. PubMed
  110. Martens A, et al. 2020. Nat Immunol. 21:381. PubMed
  111. Wang Z, et al. 2020. Autophagy. 1:. PubMed
  112. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  113. Hradilova N, et al. 2017. PLoS One. 12(2):e0171539. PubMed
  114. Yu H, et al. 2011. J Leukoc Biol. 90:205. PubMed
  115. Zhao F, et al. 2022. Front Immunol. 13:873720. PubMed
  116. Doll K, et al. 2016. J Immunol. 196: 4253 - 4262. PubMed
  117. Liu W, et al. 2016. J Virol. 90: 6085 - 6096. PubMed
  118. Fucikova J, et al. 2016. Blood. 128(26):3113-3124. PubMed
  119. Snyder LM, et al. 2022. Immunohorizons. 6:660. PubMed
  120. Douthwaite J, et al. 2017. J Immunol. 198(1):528-537. PubMed
  121. Li H, et al. 2012. J Immunol. 189:5572. PubMed
  122. Liu W, et al. 2010. J Virol. 84:12011. PubMed
  123. Elzey B, et al. 2008. Blood. 111:3684. PubMed
  124. Ries M, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006506. PubMed
  125. Rialdi A, et al. 2016. Science. 352: aad7993. PubMed
  126. Carissimo G, et al. 2019. Life Sci Alliance. 2:e201900298. PubMed
  127. Wang Y, et al. 2020. Sci Adv. 6:eaba5412. PubMed
  128. Uddin MN, et al. 2022. Brain Behav Immun Health. 26:100563. PubMed
  129. Satoh M, et al. 2016. Sci Rep. 6:28473. PubMed
  130. Shenoy AT, et al. 2021. Nat Commun. 12:5834. PubMed
  131. Ulrich-Lewis JT, et al. 2022. Front Immunol. 13:861710. PubMed
  132. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  133. Dumaine JE, et al. 2021. Elife. 10:. PubMed
  134. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  135. Jondle CN, et al. 2021. J Virol. 95:e0072621. PubMed
  136. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  137. Codo AC, et al. 2020. Cell Metab. 32:437. PubMed
  138. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  139. Tawara I, et al. 2011. Clin Cancer Res. 0.761805556. PubMed
  140. Orlov M, et al. 2017. PLoS One.. 10.1371/journal.pone.018296. PubMed
  141. Martins M, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006529. PubMed
  142. Crooks SD, et al. 2022. Immunohorizons. 6:705. PubMed
  143. Gross C, et al. 2016. Neurol Neuroimmunol Neuroinflamm. 3: e289. PubMed
  144. Krämer B, et al. 2016. PLoS One. 11: 0162068. PubMed
  145. Fang E, et al. 2022. MedComm (2020). 3:e117. PubMed
  146. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  147. Harty N 2011. J Immunol. 186:3836. PubMed
  148. Iwata Y, et al. 2011. Blood. 117:530. PubMed
  149. Cao Y, et al. 2018. Nat Commun. 2.940972222. PubMed
  150. Emmer BT, et al. 2018. Elife. 7:e38839. PubMed
  151. Lee T, et al. 2013. J Biol Chem. 288:32873. PubMed
  152. Vigano S, et al. 2015. J Virol. 89: 7829-7840. PubMed
  153. Vacaflores A, et al. 2016. PLoS One. 11: 0157175. PubMed
  154. Ma H, Wan S, Xia C 2016. J Leukoc Biol. 99: 1121 - 1129. PubMed
  155. Kim J, et al. 2016. Nat Immunol. 17:1159-1166. PubMed
  156. Johnson AM, et al. 2020. J Immunol. 204:2295. PubMed
  157. Buqué A, et al. 2020. Nat Commun. 3.110416667. PubMed
  158. Ji L, et al. 2012. PLoS One. 7:e50909. PubMed
  159. Redfern C, et al. 2006. J Clin Oncol. 24:3107. PubMed
  160. Matisz C, et al. 2017. Sci Rep. 7:40631. PubMed
  161. Castro I, et al. 2016. J Virol. 90: 5280 - 5291. PubMed
  162. Zhang W, et al. 2015. Infect Immun . 83: 3213-3223. PubMed
  163. Huang RS, et al. 2021. Curr Protoc. 1:e246. PubMed
  164. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  165. Gao Y, et al. 2022. Immunity. 55:1732. PubMed
  166. Han K, et al. 2021. Nat Metab. 3:318. PubMed
  167. Peng L, et al. 2022. Cell Rep Med. 3:100634. PubMed
  168. Bachy S, et al. 2022. iScience. 25:103758. PubMed
  169. Ohtsuka J, et al. 2021. iScience. Online ahead of print. PubMed
  170. Yan H, et al. 2020. ACS Appl Mater Interfaces. 12:19324. PubMed
  171. Ngwenyama N, et al. 2019. JCI Insight. 4:e125527. PubMed
  172. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  173. Butchar J, et al. 2010. Clin Cancer Res. 2.100694444. PubMed
  174. Wang J, et al. 2013. J Virol. 87:4372. PubMed
  175. Nice T, et al. 2016. PLoS One. 12: 1005684. PubMed
  176. Pfeifle R, et al. 2016. Nat Immunol. 18:104-113. PubMed
  177. Li Y, et al. 2021. Vaccines (Basel). 9:. PubMed
  178. Liu W, et al. 2022. Bio Protoc. 12:e4285. PubMed
  179. Ma K, et al. 2022. iScience. 25:104347. PubMed
  180. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  181. Krishnan A, et al. 2020. Am J Pathol. 190:1284. PubMed
  182. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  183. Grace PS, et al. 2021. Front Immunol. 12:679973. PubMed
  184. Molinero L, et al. 2012. Proc Natl Acad Sci U S A. 109:18529. PubMed
  185. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  186. Sekine T, et al. 2020. Cell. 183:158. PubMed
  187. Gogokhia L, et al. 2019. Cell Host Microbe. 25:285. PubMed
  188. Guo C, et al. 2018. Immunity. 49:842. PubMed
  189. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  190. Rossato C, et al. 2017. Biologicals. 10.1016/j.biologicals.2017.06.007. PubMed
  191. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  192. Matsushita T, et al. 2015. Rheumatology. 101093/rumatology/kv331. PubMed
  193. de Picciotto S, et al. 2022. Nat Commun. 13:3866. PubMed
  194. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  195. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  196. Stepanova E, et al. 2021. Microorganisms. 9:. PubMed
  197. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  198. Loeuillard E, et al. 2020. J Clin Invest. 130:5380. PubMed
  199. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  200. Rosser EC, et al. 2020. Cell Metabolism. 31(4):837-851. PubMed
  201. Zenaro E, et al. 2009. J Leukoc Biol. 86:1393. PubMed
  202. Goodridge H, et al. 2009. J Immunol. 182:1146. PubMed
  203. Gnerlich J, et al. 2010. J Immunol. 185:4063. PubMed
  204. Boisvert M, et al. 2010. J Virol. 84:7782. PubMed
  205. Langkjær A, et al. 2012. Clin Immunol. 145:1. PubMed
  206. Rozková D, et al. 2009. Clin Immunol. 131:1. PubMed
  207. Miner M, et al. 2008. Microb Pathog. 45:273. PubMed
  208. Miller M, et al. 2014. Proc Natl Acad Sci U S A. 111:7397. PubMed
  209. Gartlan K, et al. 2015. Blood. 126: 1609-1620. PubMed
  210. Ulland T, et al. 2016. Nat Commun. 7:13180. PubMed
  211. Tse SW, et al. 2021. Mol Ther. 29:2227. PubMed
  212. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  213. Melacarne A, et al. 2021. Cell Reports. 36(1):109312. PubMed
  214. Markey K, et al. 2009. Blood. 113:5644. PubMed
  215. Salazar V, et al. 2019. Cell Rep. 26:1585. PubMed
  216. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  217. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  218. Beyaz S, et al. 2016. Nat Immunol. 18:184-195. PubMed
  219. Kadivar M, et al. 2016. J Immunol. 197(12):4584-4592. PubMed
  220. Wang J, et al. 2013. J Virol. 87:11262. PubMed
  221. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  222. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  223. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  224. Li Z, et al. 2021. JCI Insight. 6:. PubMed
  225. Virtakoivu R, et al. 2021. Clin Cancer Res. 27:4205. PubMed
  226. Koschel J, et al. 2021. Cell Death Differ. 28:2257. PubMed
  227. FitzPatrick MEB, et al. 2021. Cell Rep. 34:108661. PubMed
  228. Bass VL, et al. 2021. Mol Syst Biol. 17:e10127. PubMed
  229. Theisen U, et al. 2020. J Cell Biol. :219. PubMed
  230. Dáňová K, et al. 2017. J Immunol. 198(2):729-740. PubMed
  231. Fukuoka A, et al. 2013. Int Immunol. 25:373. PubMed
  232. Landi A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.072. PubMed
  233. Bulati M, et al. 2014. Exp Gerontol. 54:123. PubMed
  234. Zhou G, et al. 2014. J Cell Sci. 127:3916. PubMed
  235. Rist M, et al. 2015. J Virol. 89:703. PubMed
  236. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  237. Gussarow D, et al. 2021. Front Med (Lausanne). 8:770381. PubMed
  238. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  239. Mohammadpour H, et al. 2020. JCI Insight. 5:00. PubMed
  240. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  241. Mackroth M, et al. 2016. PLoS Pathog. 12:e1005909. PubMed
  242. Rau M, et al. 2016. J Immunol. 196: 97 - 105. PubMed
  243. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  244. Lei Y, et al. 2021. Sci Adv. 7:. PubMed
  245. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  246. Genardi S, et al. 2020. Front Immunol. 11:610010. PubMed
  247. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  248. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  249. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  250. Ruland C, et al. 2017. Brain Behav Immun. 10.1016/j.bbi.2017.06.010. PubMed
  251. Ahmadi H,et al. 2017. Inflammopharmacology. . 10.1007/s10787-017-0410-8. PubMed
  252. Li J, et al. 2018. Redox Biol. 0.976388889. PubMed
  253. Krishna B, et al. 2016. Sci Rep. 6: 24674. PubMed
  254. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  255. Schridde A, et al. 2017. Mucosal Immunol. 10.1038/mi.2016.142. PubMed
  256. Wang W, et al. 2020. STAR Protoc. 1:100218. PubMed
  257. Lu G, et al. 2017. PLoS One. 12:e0178352. PubMed
  258. Orozco SL, et al. 2019. Cell Rep. 28:2275. PubMed
  259. Abshire C, et al. 2016. PLoS Pathog. 12:e1006088. PubMed
  260. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  261. Ying B, et al. 2022. Sci Transl Med. 14:eabm3302. PubMed
  262. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  263. Carrion B, et al. 2021. Neurol Neuroimmunol Neuroinflamm. 8:. PubMed
  264. Petrova T, et al. 2021. FEBS J. 288:5909. PubMed
  265. Nesterenko PA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  266. Matei DE, et al. 2021. Med (N Y). 2:864. PubMed
  267. Laczkó D, et al. 2020. Immunity. 53:724. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.
5. Jung T, et al. 1993. J. Immunol. Meth. 159:197.

Gene ID
NA

Related FAQs

The Brefeldin A solution freezes at 4°C . Is the solution still OK?

We recommend to thaw in warm water after removing from the fridge.  The Brefeldin A is dissolved in DMSO, which freezes at 18°C, so this is normal.  No one has reported any problems with the freeze/thaw cycles and this is how we recommend it is stored.   If customers are concerned, they can aliquot the Brefeldin A to avoid the freeze thaw.

How do I choose monensin or Brefeldin A solution?

Generally, Brefeldin A is more toxic for longer term incubations, so for shorter stimulations (6 hrs or less) use Brefeldin A.  For longer stimulations use monensin.  We recommend optimization for each cell type and protocol.

Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account